Healthcare Market Access Consultancy and Training
Leading solutions in market access discipline
About Market Access Foundation Academy
Our Mission
At Market Access Foundation Academy, we strive to leverage the skills of professionals in the Pharmaceuticals and Healthcare industries.
Our mission is to provide comprehensive training and resources that help to build effective market access strategies and expedite access for needy patients
Founder and CEO Biography
Dr. Sherif Hammad
Assistant Professor Market Access- Gulf Medical University
Head of Market Access, Marketing and Business Development- MENA/ Pharma Solutions LLC
Market Access Consultant - Middle East/ Thea Laboratories
Head of Market Access- Gulf and Levant/ Takeda Pharma
Pricing Manager - NEMEA / Takeda Pharma
About Market Access Foundation Academy
Our Vision
Our Approach
Our Vision
At Market Access Foundation Academy, our vision is to be the leading consulting firm in the industry. We aim to achieve this by constantly innovating and providing exceptional services that exceed our clients' expectations.
Our Team
Our Approach
Our Vision
Our team comprises of highly skilled consultants with extensive experience in various industries. We are committed to delivering quality services to our clients and helping them achieve their business goals.
Our Approach
Our Approach
Our Approach
We take a data-driven approach to consulting, where we use advanced analytics and technology to provide insights that drive business decisions. Our approach is highly customizable to meet the unique needs of each client.
Accredited Training Program
Our Training Program is UK Accredited
Innovative Consulting Solutions for Market Access Foundation Academy
Welcome to Market Access Foundation Academy Consulting
At Market Access Foundation Academy Consulting, we provide expert advice and guidance to businesses in need of strategic planning, marketing, and financial management. Our team of experienced consultants has a proven track record of success in helping businesses achieve their goals and reach their full potential. We are dedicated to providing personalized services tailored to meet the unique needs of each of our clients. Contact us today to learn how we can help your business thrive.
Market Access Training Contents
Topics and Contents
The topics in the teaching market access course, each topic is discussed over 3 hours in each weekend (Saturday or Sunday)
This course provides students with an understanding of market access strategy and tools for pharmaceuticals and medical technologies in the pre-marketing and post-marketing phases. Market access strategic activities will be discussed: using case-studies; focusing on the disease environment/management, outcomes research, health economics and pricing; throughout different phases: early development and late development, market launch and post launch.
Course Learning Outcomes
Upon successful completion of the course, student will be able to:
1. Demonstrate understanding of crucial market access issues
2. Identify key trends in market access and how market access decisions are made in the interaction among providers, payers and industry
3. Explain how the decision frameworks affect requirements for evidence for new health care interventions
4. Demonstrate understanding of basic market access vocabulary
5. Show understanding of the toolbox of the market access methodologies and demonstrate the skills to generate, apply and present real world evidence to maximize market access strategy.
6. As a team leader, identify the specificities and characteristics of health sector that facilitate or impede the access to it for new products.
7. Prepare independently a plan for the introduction of a new drug or health technology in a new market and employ medical terms in your plan.
Week 1:
Topic: Health as a Good
Contents:
* Healthcare: A mixed and collective good
* Equity, health and health care
Week 2:
Topic: Decision-Making in Public Health
Contents:
* Public health definition
* Organization of public health
* Criteria used for priority setting and decision making
* Monitoring and evaluation of public health policies
* Case Discussion
Week 3:
Topic: Introduction to Market Access
Contents:
* Marketing trends
* Defining global market access for the 21st centaury
* Implications for the entire organization
Week 4:
Topic: Core Concepts of Market Access
Contents:
* Defining the concepts
* Theories and methods relevant to healthcare sector
Week 5:
Topic: Introduction to epidemiology and biostatistics
Contents:
* Epidemiology
* Biostatistics
* Critical appraisal of clinical trials
Week 6:
Topic: Stakeholders – who are they, their perspectives, how and when to engage with ‘payers’.
Contents:
* Uncertainty versus risk
* Payers versus regulators
* Risk management of drug value uncertainty – HTA(Health Technology Assessment)/Payer level
* Case studies of gaps between regulatory and HTA/ Payer approval
Week 7:
Topic: Negotiation Strategy
Contents:
* Negotiation Strategy: Principles of Negotiation
* Types of negotiation techniques, ZOPA, BATNA, SPIN
* Negotiating through emails/calls
Week 8:
Topic: Introduction to Pharmacoeconomics and HTA
Contents:
1. Pharmacoeconomics
2. Health technology assessment
3. Case Discussion
Week 9:
Topic: Pricing and reimbursement
Contents:
· Pricing Techniques
· Reference pricing systems in various markets
· Case Discussion
Week 10:
Topic: Market Access Agreements
Contents:
* Definitions and taxonomies
* Payers’ and manufacturers’ motivations to implement MAAs
* International comparison of MAA health policies
* Class Discussion
Week 11:
Topic: Market Access Agreements
Contents:
* Best practices of MAAs
* Impact of MAAs on product uptake
* Case studies
* Overview of MAA trends in other countries
Week 12:
Topic: Early Access Programs
Contents:
· Types
· Global EAP trends
· EAP management
· Class Discussion
Week 13:
Topic: Market access of orphan drugs
Contents:
· Definition of orphan drugs
· Legal framework for licensing and assessment of orphan drugs
· Class Discussion
Week 14:
Topic: Market access of drugs and vaccines in Emerging and developed countries
Contents:
· Introduction
· Vaccines/Drugs specifics
· Market access in Emerging countries
· Market access in Developed countries
· Case Discussion:
Week 15:
Topic: Market Access Plan
Contents:
- Market selection and assessment
- Target product profile
- Key value preposition
- Core Value Dossier
- Market access strategy
- Execution and implementation
Other deliverables: case studies, clinical literatures, course book, clinical Quizes, MCQs and individual business case evaluation
If you want to go fast, go alone. If you want to go far, go together.
African Proverb
